ZYXI - Zynex slips after postponing Q4 2022 earnings

2023-03-07 06:37:19 ET

• Medical device maker Zynex ( NASDAQ: ZYXI ) shed ~7% pre-market Tuesday due to an abrupt decision to delay the release of its Q4 and full-year financials and a conference call, initially scheduled for Mar. 06 after the close.
• Zynex ( ZYXI ) did not cite a reason for the delay, noting that the company will announce the revised date for earnings release and conference call at a future date "to allow additional time to complete its year- end closing procedures."
• The developer of non-invasive pain management devices has more than doubled in value over the past twelve months amid favorable views on Wall Street.
• Seeking Alpha contributor Davide Ravera upgraded Zynex ( ZYXI ) to Strong Buy from Buy in November, noting that the company is finally diversifying its business, removing one of its most significant risks.
• Author Francesco Castellano agreed. "Zynex's new products are radically different from their predecessors: more specific and innovative," he wrote.

For further details see: